. Thorax, 30,[333][334][335][336]. Absorption of phenol red from the human lung. Pulmonary absorption of phenol red was studied in normal subjects. Phenol red was administered by intratracheal injection and its urinary excretion was used as an index of pulmonary absorption. Doses ranging from 3 to 30 mg were given to two subjects and urinary phenol red excretion was found to be rate limited. That this effect occurred in the lung was shown by giving the dye intravenously to one subject. A linear relationship between dose and urinary excretion was then observed.
. Thorax, 30, [333] [334] [335] [336] . Absorption of phenol red from the human lung. Pulmonary absorption of phenol red was studied in normal subjects. Phenol red was administered by intratracheal injection and its urinary excretion was used as an index of pulmonary absorption. Doses ranging from 3 to 30 mg were given to two subjects and urinary phenol red excretion was found to be rate limited. That this effect occurred in the lung was shown by giving the dye intravenously to one subject. A linear relationship between dose and urinary excretion was then observed.
Intratracheal p-aminohippurate did not reduce pulmonary absorption of phenol red in one subject.
Pulmonary absorption of phenol red dissolved in 0-9% saline and in 018% saline was compared in nine subjects. Dye absorption was three times greater when it was given in 0 18% saline.
When the saline concentration of phenol red doses was held constant there was a linear relationship between the intratracheal dose and urinary excretion in one subject.
These results suggest that phenol red is absorbed from the lung by passive diffusion.
They also show the importance of solvent effects when studying pulmonary absorption of a substance.
Little is known of the quantitative aspects of pulmonary absorption of drugs in man (Schanker, 1972) . In this study phenol red (PSP) was used to study pulmonary absorption as it is non-toxic, non-irritant to the lungs, and is rapidly eliminated in the urine (Abramson et al., 1949 Before receiving an intratracheal injection of PSP each subject passed urine and drank 500 ml of water to ensure that urine could be passed during the experiment. All urine passed by each subject 0 5, 1, 2, and 3 hours after the intratracheal injection was collected and its volume measured.
PSP was assayed spectrophotometrically at 560 nm after the addition of 5N sodium hydroxide (1 ml per 100 ml of urine) and filtration. Control urine collections from each subject were used for blank readings. Recovery of PSP added to urine was complete.
RESULTS

INTRATRACHEAL DOSE OF PSP AND ITS URINARY
EXCRETION The relationship between the intratracheal dose and urinary excretion of PSP was studied in subjects J.M. and D.G. Each dose was prepared from PSP solution (6 mg per ml in 0-9% saline) and its volume was made up to 5 ml with water. Saline concentrations of the doses were therefore variable and were lowest in the smallest doses. The results are shown in Table I . Although there was a tenfold range of dosage, the urinary excretion of PSP in the first hour after injection of doses ranging from 3 to 18 mg was fairly constant (1 1-13 mg) and only a little higher (mean= 18 mg) after the 30 mg dose. There was thus evidence of rate limitation of PSP excretion after intratracheal administration. The relationship between the intravenous dose of PSP and its urinary excretion was studied to determine whether rate limitation of excretion observed after intratracheal injection occurred in the kidney. Intravenous doses of 0 5, 1 0, 1 5, and 3 0 mg respectively of PSP dissolved in 4 ml of 0 9% saline were given to subject J.M. weekly, and the urinary PSP in the first hour after the dose was measured. As shown in Fig. 1 , there was a linear relationship between the intravenous dose and the amount of PSP in the urine in the first hour after the dose. This experiment was repeated in J.M. with similar findings, indicating that biliary excretion of PSP is constant under the same experimental conditions. Similar results have recently been observed in six normal subjects (Williams and Maddocks, 1975 (Schanker, 1962) . The effect of intratracheal p-aminohippurate on PSP absorption was therefore studied. By intratracheal injection 18 mg of PSP (3 ml of PSP solution + 2 ml of water) was given to subject J.M., and its cumulative weight was measured in the urine after 0 5, 1, and 2 hours. A week later 18 mg of PSP together with 100 mg of sodium p-aminohippurate (volume of dose made up to 5 ml with water) was given by intratracheal injection and the urinary excretion of PSP was measured as before. This experimen't was performed twice. The results are shown in Table II 09% saline and also in 0 18% saline; to four subjects it was given in 0-9% saline and to the other three subjects in 018% saline. As shown in Table III , the mean weight of PSP excreted in the urine in the first hour was three times greater when it was given in 0-18% saline (1 2+032 mg) compared with the same dose in 0-9% saline (0-41+r0-09 mg). The difference between the means was statistically significant (P<0001). (mg) of PSP in 0 9% (isotonic) saline and its total urinary excretion (mg) 0 5 hr (fc-fc), 1 hr (A-A). and 2 hr (e-) after the dose. was found to be directly proportional to the dose. Also, intratracheal p-aminohippurate did not reduce PSP absorption from the lung. Both these observations suggest that pulmonary absorption of PSP occurs by passive diffusion. Similar results were obtained for pulmonary absorption of ampicillin in man (Maddocks, 1974) and organic acids in the rat (Enna and Schanker, 1969) . It is possible that the intratracheal lignocaine used in this study might interfere with active absorption of PSP from the lung. There is no direct evidence to exclude this effect at present. However, Eriksson and Granberg (1965) , in their studies on the renal effects of lignocaine in man, found no evidence that it blocked the tubular mechanism for organic acids which actively transports both PSP and p-aminohippurate. They found no impairment of p-aminohippurate or inulin clearance even when large doses of lignocaine were given together with p-aminohippurate intravenously. The suggestion by May and Delves (1965) that there might be an active transport mechanism for ampicillin in the bronchus similar to that for organic acids in the kidney, liver (Sperber, 1959) , choroid plexus (Pappenheimer, Heisey, and Jordan, 1961) , and ciliary body (Becker, 1960) has not been confirmed. Viable human bronchial slices do not accumulate ampicillin (Maddocks, 1975) or p-aminohippurate (Maddocks, 1973) so it is more likely that these drugs cross the bronchial mucosa by passive diffusion.
The more rapid absorption of PSP from 018% (hypotonic) saline than from 0-9% (isotonic) saline found in this study might be due to pulmonary absorption of water. In fresh water drowning, water is known to be rapidly absorbed from the human lung (Moritz, 1944) , and Qualls, Curtis, and Meneely (1953) showed that water was very rapidly absorbed from the canine lung with a half-time of 3 8 minutes. Absorption of water from a hypotonic PSP solution would tend to increase the concentration of dye in the lung so that its absorption increases. Another possible factor that might increase the rate of PSP absorption from hypotonic solutions is 'solvent drag'. This occurs when water is absorbed through membrane 'pores' and drags with it hydrophilic molecules so that they cross the membrane faster than can be explained by diffusion alone. Thus water absorption increases the rate of PSP absorption from the canine jejunum (Tidball and Peterson, 1961) and urea absorption from the rat jejunum (Ochsenfahrt and Winne, 1973) .
Pulmonary absorption of PSP in this study was found to be much greater than in published results for its gastrointestinal absorption in man. One hour after an oral dose of 30 mg to four normal subjects, the mean urinary excretion of PSP was 0-23 mg (McCleod et al., 1968) , whereas with the same dose given by intratracheal injection to two subjects in this study the result was 1-8 mg. Enna and Schanker (1969) reported similar results for inulin (mol. wt 5000). Although not absorbed from the gut, it is significantly absorbed from the lung in the rat. Possibly the lungs have a greater permeability than the gastro-intestinal tract, although other factors such as surface area of the membrane and the effect of secretions on absorption of substances have also to be considered.
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